Tumor-associated antigens and neoantigens released by the dying cells cultivate tumor antigen-specific CD4+ and CD8+ T cell responses (Workenhe and Mossman, 2014; Kaufman et al., 2015). This evidence concerns the gene CD8A and neoplasm.